Edition:
India

Argos Therapeutics Inc (ARGS.OQ)

ARGS.OQ on NASDAQ Stock Exchange Capital Market

1.35USD
23 Feb 2018
Change (% chg)

$-0.01 (-0.74%)
Prev Close
$1.36
Open
$1.37
Day's High
$1.38
Day's Low
$1.33
Volume
25,769
Avg. Vol
99,913
52-wk High
$31.50
52-wk Low
$1.33

Chart for

About

Argos Therapeutics, Inc. (Argos) is an immuno-oncology company. The Company is focused on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its technology platform called Arcelis. The Company's Arcelis technology platform utilizes biological... (more)

Overall

Beta: 1.34
Market Cap(Mil.): $9.79
Shares Outstanding(Mil.): 54.97
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.60
EPS (TTM): -- -- --
ROI: -- 14.91 10.66
ROE: -- 16.41 14.30

BRIEF-Argos Obtains Option To License PD1 Checkpoint Inhibitors

* ARGOS THERAPEUTICS INC - ENTERED INTO AN OPTION AGREEMENT WITH PHARMSTANDARD INTERNATIONAL, S.A. AND ACTIGEN LIMITED

06 Feb 2018

BRIEF-Argos Therapeutics Board Approves One-For-Twenty Reverse Split Of Co's Common Stock Effective Jan 18, After Close

* ARGOS THERAPEUTICS - BOARD APPROVED ONE-FOR-TWENTY REVERSE SPLIT OF CO'S COMMON STOCK THAT WILL TAKE EFFECT JANUARY 18, AFTER CLOSE OF TRADING Source text for Eikon: Further company coverage:

18 Jan 2018

BRIEF-Argos Announces $1.5 Million Equity Investment By Lummy (Hong Kong) Ltd

* ARGOS ANNOUNCES $1.5 MILLION EQUITY INVESTMENT BY LUMMY (HONG KONG), LTD. Source text for Eikon: Further company coverage:

08 Jan 2018

BRIEF-Argos Therapeutics Enters Into Agreement With Saint-Gobain Performance Plastics Corp

* ARGOS THERAPEUTICS - ‍ON NOV 22, ENTERED INTO A SATISFACTION AND RELEASE AGREEMENT WITH SAINT-GOBAIN PERFORMANCE PLASTICS CORP - SEC FILING

28 Nov 2017

BRIEF-Argos Provides Financial Update

* ARGOS THERAPEUTICS - ‍TKC PROPERTIES HAS, WITH ARGOS' FULL CONSENT, SUCCESSFULLY COMPLETED SALE OF FACILITY IN DURHAM COUNTY, NC TO A THIRD PARTY​

28 Nov 2017

BRIEF-Argos reports third quarter financial results

* Argos reports third quarter 2017 financial results and operational highlights

10 Nov 2017

BRIEF-Argos Therapeutics files for offering of 13.5 mln shares of common stock by Invetech

* Argos Therapeutics files for offering of 13.5 million shares of common stock by Invetech Pty Ltd - SEC filing Source text: (http://bit.ly/2zcHDkV) Further company coverage:

04 Nov 2017

BRIEF-Argos Therapeutics enters into agreement with Invetech

* Argos Therapeutics - On September 22, 2017 co entered into a satisfaction and release agreement with Invetech PTY Ltd ‍​ - SEC filing

25 Sep 2017

BRIEF-‍Argos doses first HIV patient with AGS-004

* ‍Argos announces first dosing of HIV patient with AGS-004 derived from latent viral reservoir​

06 Sep 2017

Earnings vs. Estimates